Pursuant Regulation 29(2) and 30 of SEBI (LODR) Regulation 2015 the Board Meeting is scheduled on 14-10-2025 to Consider Approve the Sale of Factory and Office Premises as set our in the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Colinz Laboratories has called a board meeting on 14th October 2025 at 5:00 p.m. at its registered office in Bhandup, Mumbai. The board will consider and approve the sale, lease, or disposal of its factory at Sinnar and its office premises at Bhandup (described as an Undertaking). Since this is a material disposal, shareholder approval will be sought via a postal ballot through a Special Resolution. The company will also appoint a Scrutinizer to oversee the postal ballot process. The CIN listed is L24200MH1986PLC041128 and the BSE code is 531210.
This is a significant asset divestment — the company is looking to exit its factory and main office, which are core operational assets. Shareholders will vote on the disposal via postal ballot, so the terms and sale price will be critical. The stock may see volatility depending on the deal valuation and what the company plans to do with the proceeds.